These studies identified ecDNA hubs in cells derived from multiple cancer types and harboring amplifications of MYC, FGFR2, and EGFR oncogenes, suggesting that ecDNA hubs represent a common mechanism by which ecDNAs can drive oncogene overexpression. The gene discussed is FGFR2; the disease is cancer.